Swedish online pharmacy Apotea made a significant debut on the Stockholm Stock Exchange, surging 43% on its first day of trading. The IPO attracted strong demand, with the stock reaching an intra-day high of 50% before closing at a 43% gain. This listing is considered one of the largest IPOs in Sweden for the year, bringing in over 90,000 new shareholders. Analysts are discussing the implications of this successful listing for consumer-related stocks on the market, with some expressing caution about potential operational uncertainties ahead of 2025. Additionally, other companies such as Intea and KB Components are preparing for listings in the coming week, indicating a broader trend of renewed market activity.
Om hur Apotea fått rätt fokus i styrelsen. Fler borde följa detta recept! @apotea_se #apotea @dagensindustri https://t.co/cHthdt48oF
Under den gånga veckan har #Afv skrivit om: #Rottneros, #Vaxxa, #VolvoCars, #Heimstaden Pref, #KBComponents, #EnvarHolding, #Integrum, #Systemair, #Doxa, #Intea, #Apotea och #Eyeon https://t.co/ziyxzp6xZa
Die Börsen kannten in dieser Woche kein Halten. Doch ob sich diese Aufwärtsdynamik in der kommenden Woche fortsetzt, ist ungewiss. https://t.co/dSDSP6er5J